2013-01-11 14:32:09 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:

Report Summary for: Paik Kwang Industral Co Ltd is an above average quality company with a neutral outlook. Paik Kwang Industral Co Ltd has strong business growth and is run by passable management. The trend in Paik Kwang Industral Co Ltd fair value exchange rate against its closest rated-competitor, KP Chemical Corp, has been stable over the past 2 weeks. When compared to its closest competitor, Paik Kwang Industral Co Ltd shows greater undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics

at:
www.sadifanalytics.com/stockmarks/company-96-1340

Report Summary for: HMC INVESTMENT SECURITIES CO., LTD is an above average quality company with a positive outlook. HMC INVESTMENT SECURITIES CO., LTD has strong business growth and is run by passable management. The trend in HMC INVESTMENT SECURITIES CO., LTD fair value exchange rate against its closest rated-competitor, SHINYOUNG SECURITIES CO LTD, has been depreciating over the past 2 weeks. When compared to its closest competitor, HMC INVESTMENT SECURITIES CO., LTD shows greater overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-1500

Report Summary for: Ahn-Gook Pharmaceutical Co., Ltd. is an above average quality company with a neutral outlook. Ahn-Gook Pharmaceutical Co., Ltd. has strong business growth and is run by passable management. The trend in Ahn-Gook Pharmaceutical Co., Ltd. fair value exchange rate against its closest rated-competitor, Boryung Pharmaceutical Co., Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Ahn-Gook Pharmaceutical Co., Ltd. shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-1540

Report Summary for: Cheil Grinding Wheel Ind. Co., Ltd. is an above average quality company with a neutral outlook. Cheil Grinding Wheel Ind. Co., Ltd. has strong business growth and is run by efficient management. The trend in Cheil Grinding Wheel Ind. Co., Ltd. fair value exchange rate against its closest rated-competitor, Iljin Diamond Co Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Cheil Grinding Wheel Ind. Co., Ltd. shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-1560

Report Summary for: Shin Hwa Silup Co., Ltd. is a below average quality company with a negative outlook. Shin Hwa Silup Co., Ltd. has weak business growth and is run by passable management. The trend in Shin Hwa Silup Co., Ltd. fair value exchange rate against its closest rated-competitor, Samhyun Steel Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Shin Hwa Silup Co., Ltd. shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-1770

Report Summary for: KUNWHA Pharmaceutical Co., Ltd. is an above average quality company with a positive outlook. KUNWHA Pharmaceutical Co., Ltd. has medium business growth and is run by passable management. The trend in KUNWHA Pharmaceutical Co., Ltd. fair value exchange rate against its closest rated-competitor, Jin Yang Pharmaceutical Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, KUNWHA Pharmaceutical Co., Ltd. shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-2250

Report Summary for: Hankook Tire Worldwide Co Ltd is an average quality company with a positive outlook. Hankook Tire Worldwide Co Ltd has strong business growth and is run by efficient management. The trend in Hankook Tire Worldwide Co Ltd fair value exchange rate against its closest rated-competitor, Kumho Tire Co Inc, has been depreciating over the past 2 weeks. When compared to its closest competitor, Hankook Tire Worldwide Co Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-240

Report Summary for: Bukwang Pharmaceutical Co., Ltd. is an average quality company with a positive outlook. Bukwang Pharmaceutical Co., Ltd. has medium business growth and is run by efficient management. The trend in Bukwang Pharmaceutical Co., Ltd. fair value exchange rate against its closest rated-competitor, HANALL BIOPHARMA, has been depreciating over the past 2 weeks. When compared to its closest competitor, Bukwang Pharmaceutical Co., Ltd. shows less overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-3000

Report Summary for: Sungbo Chemical Co., Ltd. is an average quality company with a negative outlook. Sungbo Chemical Co., Ltd. has weak business growth and is run by passable management. The trend in Sungbo Chemical Co., Ltd. fair value exchange rate against its closest rated-competitor, MOORIM SP Co., Ltd., has been depreciating over the past 2 weeks. When compared to its closest competitor, Sungbo Chemical Co., Ltd. shows similar undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-96-3080


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.